A way for delivering genetic materials to the physique is being examined as a strategy to restore broken coronary heart muscle after a coronary heart assault. The bottom-breaking analysis is offered at this time at Frontiers in CardioVascular Biomedicine 2022, a scientific congress of the European Society of Cardiology (ESC).
The COVID-19 messenger RNA (mRNA) vaccines use lipid nanoparticles (tiny fats droplets) to ship mRNA to the physique’s cells. This mRNA instructs the cells to fabricate a dummy spike protein on their floor to imitate the protein on the virus inflicting COVID-19. The physique then mounts an immune response by creating antibodies which can be utilized if the person turns into contaminated with the virus.
An identical methodology for mRNA supply was used within the present examine. Nonetheless, as an alternative of aiming for an immune response, the researchers’ final purpose is to instruct the center’s cells to restore themselves after a coronary heart assault.
This preliminary examine was performed to find out whether or not mRNA may very well be efficiently delivered to the center muscle in lipid nanoparticles. The researchers injected totally different formulations into the left ventricular wall of mouse hearts throughout open chest surgical procedure beneath normal anesthesia. Twenty-four hours after administration, the mice had been sacrificed and the situation of mRNA translation was examined.
The researchers discovered that mRNA efficiently reached the center cells 24 hours after injection. Nonetheless, regardless of injection into the center, the best ranges of mRNA translation had been present in cells of the liver and spleen.
Excessive expression was anticipated within the liver, because it metabolizes the lipid nanoparticles. Nonetheless, it was encouraging to see that there was mRNA translation within the coronary heart tissue which implies that lipid nanoparticles may work as supply methods for mRNA remedy.”
dr Clara Labonia, examine writer, College Medical Heart Utrecht, the Netherlands
She concluded: “The subsequent step of this analysis is to check extra formulations and select the one which most effectively targets the center tissue. We are going to then assess whether or not supply of mRNA to mice with ischemic hearts (resembling a coronary heart assault) has any therapeutic impact .”
sources:
European Society of Cardiology
